Mike Castro

12PUBLICATIONS
109CO-AUTHORS
Innate immunityInfectious diseasesNanomedicineHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 19, 2026
A Randomized, Double-Blind Clinical Trial of One vs Two Doses of High-Dose Influenza Vaccine in Solid Organ Transplant Recipients.

|Apr 15, 2026
SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.

|Sep 01, 2025
Hyaluronidase-enhanced subcutaneous delivery of bNAbs: a phase 1 randomized controlled clinical trial in HIV-uninfected women.

Sharana Mahomed, Farzana Osman, Martin Beliveau

|Jun 03, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.

Kenta Matsuda, Mitra Harrison, Eleanor Wettstein

|Nov 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Lindsay N Carpp, Ollivier Hyrien, Youyi Fong

|Sep 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.

Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner

Pageof 2

Frequent Collaborators

6 joint publications

Adrian B McDermott

3 joint publications

Vrc Production Program

3 joint publications

Sarah F Andrews

3 joint publications

Bob C Lin